Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:drug |
| gptkbp:ATCCode |
N05CM17
|
| gptkbp:CASNumber |
36596-29-9
|
| gptkbp:developedBy |
gptkb:Merck
gptkb:Lundbeck |
| gptkbp:discontinued_development |
2007
|
| gptkbp:hasInChIKey |
QKQKJJQHZGZGHL-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C7H10N2O2
|
| gptkbp:hasSMILES |
C1CC2=C(C(=NO2)O)N=C1
|
| gptkbp:hasUNII |
YFQ6T1K74X
|
| https://www.w3.org/2000/01/rdf-schema#label |
gaboxadol
|
| gptkbp:IUPACName |
gptkb:4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol
|
| gptkbp:legalStatus |
investigational
|
| gptkbp:mechanismOfAction |
GABAA receptor agonist
|
| gptkbp:molecularWeight |
154.17 g/mol
|
| gptkbp:PubChem_CID |
3478
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
gptkb:4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol
gptkb:THIP |
| gptkbp:usedFor |
treatment of insomnia
|
| gptkbp:bfsParent |
gptkb:THIP
|
| gptkbp:bfsLayer |
7
|